JP6603785B2 - 水溶性高分子を含む水性液剤 - Google Patents

水溶性高分子を含む水性液剤 Download PDF

Info

Publication number
JP6603785B2
JP6603785B2 JP2018229557A JP2018229557A JP6603785B2 JP 6603785 B2 JP6603785 B2 JP 6603785B2 JP 2018229557 A JP2018229557 A JP 2018229557A JP 2018229557 A JP2018229557 A JP 2018229557A JP 6603785 B2 JP6603785 B2 JP 6603785B2
Authority
JP
Japan
Prior art keywords
salt
aqueous liquid
brimonidine
water
soluble polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018229557A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019104727A (ja
JP2019104727A5 (enExample
Inventor
涼香 家本
涼 杉原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of JP2019104727A publication Critical patent/JP2019104727A/ja
Publication of JP2019104727A5 publication Critical patent/JP2019104727A5/ja
Application granted granted Critical
Publication of JP6603785B2 publication Critical patent/JP6603785B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018229557A 2017-12-08 2018-12-07 水溶性高分子を含む水性液剤 Active JP6603785B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017235962 2017-12-08
JP2017235962 2017-12-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019096298A Division JP6701412B2 (ja) 2017-12-08 2019-05-22 水溶性高分子を含む水性液剤

Publications (3)

Publication Number Publication Date
JP2019104727A JP2019104727A (ja) 2019-06-27
JP2019104727A5 JP2019104727A5 (enExample) 2019-08-08
JP6603785B2 true JP6603785B2 (ja) 2019-11-06

Family

ID=66751450

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018229557A Active JP6603785B2 (ja) 2017-12-08 2018-12-07 水溶性高分子を含む水性液剤
JP2019096298A Active JP6701412B2 (ja) 2017-12-08 2019-05-22 水溶性高分子を含む水性液剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019096298A Active JP6701412B2 (ja) 2017-12-08 2019-05-22 水溶性高分子を含む水性液剤

Country Status (2)

Country Link
JP (2) JP6603785B2 (enExample)
WO (1) WO2019112030A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6628924B2 (ja) * 2018-06-05 2020-01-15 千寿製薬株式会社 水性液剤
JP2020033290A (ja) * 2018-08-29 2020-03-05 興和株式会社 水性組成物
TWI833913B (zh) * 2019-02-27 2024-03-01 日商參天製藥股份有限公司 含有迪夸弗索(diquafosol)或其鹽、乙烯系高分子及纖維素系高分子之眼科用組合物
JP6797992B1 (ja) * 2019-09-30 2020-12-09 千寿製薬株式会社 水性液剤
JP6798001B1 (ja) * 2019-12-27 2020-12-09 千寿製薬株式会社 医薬製品
CN117571883B (zh) * 2024-01-15 2024-03-19 四川智强医药科技开发有限公司 一种酒石酸溴莫尼定滴眼液的质量检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3499882B2 (ja) * 1992-03-09 2004-02-23 日本製薬株式会社 粘性すり込み用消毒剤
JPH07267840A (ja) * 1994-03-30 1995-10-17 Sunstar Inc 口腔用組成物
JPH10203960A (ja) * 1997-01-24 1998-08-04 Ofutekusu:Kk 点眼液組成物
JP2011042682A (ja) * 1997-05-20 2011-03-03 Senju Pharmaceut Co Ltd 水性製剤の増粘剤
WO2004073708A1 (en) * 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2003216213B2 (en) * 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US9089562B2 (en) * 2013-08-28 2015-07-28 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
SG10201901426WA (en) * 2015-03-06 2019-03-28 Santen Pharmaceutical Co Ltd Ophthalmic composition
CN107427460A (zh) * 2015-03-19 2017-12-01 阿勒根公司 溴莫尼定和噻吗洛尔的固定剂量组合
HK1244689A1 (zh) * 2015-05-28 2018-08-17 乐敦制药株式会社 水性眼科组合物
TWI711453B (zh) * 2015-06-05 2020-12-01 日商參天製藥股份有限公司 抑制水性點眼液中之洛赫西定類的殘存率降低之方法
TW201733577A (zh) * 2016-03-14 2017-10-01 Santen Pharmaceutical Co Ltd 含有多佐胺、噻嗎洛爾和界面活性劑之醫藥組成物

Also Published As

Publication number Publication date
JP6701412B2 (ja) 2020-05-27
WO2019112030A1 (ja) 2019-06-13
JP2019104727A (ja) 2019-06-27
JP2019142974A (ja) 2019-08-29

Similar Documents

Publication Publication Date Title
JP6603785B2 (ja) 水溶性高分子を含む水性液剤
CN102958509B (zh) 用于不含防腐剂的非粘性前列腺素类溶液的聚合物给药系统
JP7524272B2 (ja) 水溶性高分子を含む点眼剤
JP6491588B2 (ja) ピリジルアミノ酢酸化合物を含む医薬製剤
JP2019108320A (ja) ソフトコンタクトレンズの変質を抑制する眼科用組成物
KR20130100273A (ko) 점안용 수성 조성물
KR102365008B1 (ko) 디쿠아포솔을 포함하는 점안 조성물
JP2025106604A (ja) 眼科用組成物
KR20220068131A (ko) 세티리진 및 토코페솔란을 포함하는 안과용 조성물
WO2007007894A1 (ja) キサンタンガムおよびテルペノイドを含有する点眼剤
JP2022548221A (ja) シクロスポリンおよびメントール含有ナノエマルジョン点眼組成物およびその製造方法
KR20230145458A (ko) 우르소데옥시콜산 또는 그 염을 함유하는 수성 의약 조성물
JP6730500B2 (ja) 水性液剤
CA2758858C (en) Aqueous ophthalmic compositions containing anionic therapeutic agents
CN110022856B (zh) 用于降低眼压的眼用组合物
JP7566670B2 (ja) 眼圧下降用組成物
JP7534129B2 (ja) 多成分配合点眼剤
JP2022109891A (ja) 安定化された４成分配合点眼剤
JP6571391B2 (ja) 水性製剤
GR1009616B (el) Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου
WO2019123266A1 (en) Ophthalmic composition having a prostaglandin and a beta-blocker
HK40005358B (en) Eye-drop composition for lowering intraocular pressure

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190522

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190522

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190912

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191001

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191011

R150 Certificate of patent or registration of utility model

Ref document number: 6603785

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250